Date: 2025/05/18 - 16:31
Semaglutide, available under the brand names Ozempic and Wegovy, may help decrease the risk of major adverse cardiovascular events after just six months of starting the medication, a new study indicates.
Date: 2025/05/17 - 01:32
“Broken heart syndrome” carries a significant risk of death and serious complications. Although the condition appears to be much more common in women, men may be significantly more likely to die from it, according to new research.
Date: 2025/05/15 - 23:32
Federal regulators have accepted Novo Nordisk’s application to produce a pill version of its injectable weight-loss medication Wegovy. Experts say an oral medication for weight loss might be more cost effective and easier for people to use.
Date: 2025/05/13 - 23:32
First-generation GLP-1 weight-loss drugs can help reduce the risk of obesity-related cancers, new research shows. Liraglutide, exenatide, and dulaglutide were 41% more effective at preventing obesity-related cancers.
Date: 2025/05/09 - 17:00
People who receive the shingles vaccine have a 23% lower risk of cardiovascular events, such as stroke, and coronary heart disease, with this protection lasting for up to 8 years, anew study finds.
Date: 2025/05/07 - 23:32
Researchers have developed a method for measuring the heart's “functional age” to help predict complications like heart disease. According to the authors of a new study, premature aging of the heart is linked to unhealthy lifestyle habits.
Date: 2025/05/07 - 22:00
Republican leaders are considering drastic cuts to Medicaid funding. The cuts could have a significant impact on low-income households, older adults, children, and people with mental health disorders. Reduced federal funding could also affect access to reproductive health services.